Cancellation Notice Sent To 31 Companies, Including Patanjali, In Mihan-SEZ

Nagpur : The office of the development commissioner (DC) has issued a communication to 31 companies allotted land in Mihan saying that it has been decided to cancel their permission to operate in the SEZ. This includes Patanjali Ayurveda, which has got over 100 acres of land in the SEZ.

The action comes following a review into the status of units in Mihan by the DC’s office. It was found that no records of letters of approval (LOA) were found for 11 companies, but land was shown in their name. For the rest, the LOA had expired, yet the land was in their name.

The LOA is the basic requirement for a unit to operate in an SEZ. In other words, it’s like a licence. The LOA comes from the DC office or Board of Approvals (BOA), in case the investor is a co-developer. Both come under the ministry of commerce. Each SEZ has a DC. The review shows that nearly half of the companies in the SEZ had a valid LOA or did not have one at all, said sources.

Patanjali, which has over 230 acres in the domestic tariff area (DTA) also has 106 acres within the SEZ. The company was allotted land in 2017. The LOA which expired after the first term was not extended, said a source.

Similarly, M/s Vipul Karamchand, a developer is shown to have 54 acres in its name. However, no records of LOA were found, the source said.

This is for the first time such letters have been issued from the DC. Sraman Vasireddy, the DC for Mihan-SEZ, confirmed the development saying that a response has been sought from the companies.

An independent source said this means the units may have to wind up from Mihan-SEZ or else even if the operations are taken up, the tax benefits would not be available. In all these cases, none of the companies has started operations, said sources.

The MADC, which is a state government company, has also been pulled up.

It all began with a review of non-starters. The companies are supposed to start operations within a year of the issuance of LOA. After that, extensions can be issued for 2-3 years. The subsequent extensions have to come from the BOA, said sources.

Five of the companies had taken co-developer status, which means they can let out to other investors. No work was done on the sites, said a source.

Without an LOA, the company ceases to exist in an SEZ. The next step would be to formally strike off these companies names, a source said.

  • Related Posts

    Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annually

    Starting November 9, prices for 137 anti-cancer drugs across various brands will drop significantly after the government capped trade margins. The move is expected to generate an estimated annual savings…

    Nigeria’s Anti-Narcotics Agency Uncovers Drug Shipments Concealed In Sofas, Snacks, Detergents And Women’s Headwear

    The National Drug Law Enforcement Agency (NDLEA) has uncovered several attempts to smuggle illicit drugs into and out of Nigeria, with traffickers concealing substances in wooden sofas, cartons of snacks,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annually

    Cancer drug prices to fall by up to 96% from November 9; consumers set to save Rs 3,502 crore annually

    Nigeria’s Anti-Narcotics Agency Uncovers Drug Shipments Concealed In Sofas, Snacks, Detergents And Women’s Headwear

    Nigeria’s Anti-Narcotics Agency Uncovers Drug Shipments Concealed In Sofas, Snacks, Detergents And Women’s Headwear

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    FDA seizes food stock worth Rs 63.45 crore, suspends 954 licences in two months

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    Stents to syringes: Serious harm reports surge, but makers remain unnamed

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    NPPA Revises Retail and Ceiling Prices of 35 Drug Formulations; Fixes Prices of 34 New Drugs, Cholecalciferol, Oxaliplatin and Sun Pharma’s Diclofenac Gel

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru

    ED attaches assets, freezes bank account in counterfeit medicines racket; searches five premises in Bengaluru